Literature DB >> 20566347

Spatio-temporal localization of vasoactive intestinal peptide and neutral endopeptidase in allergic murine lungs.

Amali E Samarasinghe1, Scott A Hoselton, Jane M Schuh.   

Abstract

Vasoactive intestinal peptide (VIP) is a neuropeptide with cytokine properties that is abundant in the lung. VIP null mice exhibit spontaneous airway inflammation and hyperresponsiveness emphasizing VIP's "anti-asthma" potential. Although VIP's impending protective role in the lung has been demonstrated, its localization in the naïve and allergic murine lungs has not. To this aim, we analyzed the availability of VIP and its protease, neutral peptidase (NEP), in naïve and Aspergillus-sensitized and challenged murine lungs after 3, 7, and 14days. Both VIP and NEP were predominantly localized to the columnar epithelia of the airways in naïve lungs. A marked decrease in VIP occurred in these cells 3days after allergen challenge. NEP localization in the columnar epithelia decreased after allergen challenge. At day 14, VIP localization in the columnar epithelia and arteriolar smooth muscle increased while NEP localization at these sites remained low. This study provides new insights into the local regulation of VIP in the columnar epithelia of the allergic lung. Its altered availability in the context of allergy provides fresh evidence for the modulation of pulmonary inflammation by VIP. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20566347      PMCID: PMC2926301          DOI: 10.1016/j.regpep.2010.05.017

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  48 in total

1.  Vasoactive intestinal peptide counteracts leukotriene D4-induced contractions of guinea pig trachea, lung, and pulmonary artery.

Authors:  Y Hamasaki; T Saga; M Mojarad; S I Said
Journal:  Trans Assoc Am Physicians       Date:  1983

2.  Release of vasoactive intestinal polypeptide in mast cells by histamine liberators.

Authors:  E Cutz; W Chan; N S Track; A Goth; S I Said
Journal:  Nature       Date:  1978-10-19       Impact factor: 49.962

3.  Localization of VIP-immunoreactive nerves in airways and pulmonary vessels of dogs, cat, and human subjects.

Authors:  R D Dey; W A Shannon; S I Said
Journal:  Cell Tissue Res       Date:  1981       Impact factor: 5.249

4.  Mice lacking the VIP gene show airway hyperresponsiveness and airway inflammation, partially reversible by VIP.

Authors:  Anthony M Szema; Sayyed A Hamidi; Sergey Lyubsky; Kathleen G Dickman; Suni Mathew; Tarek Abdel-Razek; John J Chen; James A Waschek; Sami I Said
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2006-06-16       Impact factor: 5.464

5.  Vasoactive intestinal peptide enhances wound healing and proliferation of human bronchial epithelial cells.

Authors:  Cha-Xiang Guan; Min Zhang; Xiao-Qun Qin; Yan-Ru Cui; Zi-Qiang Luo; Hong-Bo Bai; Xiang Fang
Journal:  Peptides       Date:  2006-09-11       Impact factor: 3.750

6.  Substance P-, VIP-, and enkephalin-like immunoreactivity in the human vagus nerve.

Authors:  J M Lundberg; T Hökfelt; J Kewenter; G Pettersson; H Ahlman; R Edin; A Dahlström; G Nilsson; L Terenius; K Uvnäs-Wallensten; S Said
Journal:  Gastroenterology       Date:  1979-09       Impact factor: 22.682

7.  Neutral endopeptidase 24.11 in human neutrophils: cleavage of chemotactic peptide.

Authors:  J C Connelly; R A Skidgel; W W Schulz; A R Johnson; E G Erdös
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

8.  Damage of the airway epithelium and bronchial reactivity in patients with asthma.

Authors:  L A Laitinen; M Heino; A Laitinen; T Kava; T Haahtela
Journal:  Am Rev Respir Dis       Date:  1985-04

9.  A substance P antagonist inhibits vagally induced increase in vascular permeability and bronchial smooth muscle contraction in the guinea pig.

Authors:  J M Lundberg; A Saria; E Brodin; S Rosell; K Folkers
Journal:  Proc Natl Acad Sci U S A       Date:  1983-02       Impact factor: 11.205

10.  Neutral metalloendopeptidase in human lung tissue and cultured cells.

Authors:  A R Johnson; J Ashton; W W Schulz; E G Erdös
Journal:  Am Rev Respir Dis       Date:  1985-09
View more
  7 in total

1.  μ-chain-deficient mice possess B-1 cells and produce IgG and IgE, but not IgA, following systemic sensitization and inhalational challenge in a fungal asthma model.

Authors:  Sumit Ghosh; Scott A Hoselton; Jane M Schuh
Journal:  J Immunol       Date:  2012-06-25       Impact factor: 5.422

2.  Radical reversal of vasoactive intestinal peptide (VIP) receptors during early lymphopoiesis.

Authors:  Emilie E Vomhof-DeKrey; Ashley R Sandy; Jarrett J Failing; Rebecca J Hermann; Scott A Hoselton; Jane M Schuh; Abby J Weldon; Kimberly J Payne; Glenn P Dorsam
Journal:  Peptides       Date:  2011-08-22       Impact factor: 3.750

3.  Hyaluronan deposition and co-localization with inflammatory cells and collagen in a murine model of fungal allergic asthma.

Authors:  Sumit Ghosh; Amali E Samarasinghe; Scott A Hoselton; Glenn P Dorsam; Jane M Schuh
Journal:  Inflamm Res       Date:  2014-02-12       Impact factor: 4.575

Review 4.  Neuroendocrine cells derived chemokine vasoactive intestinal polypeptide (VIP) in allergic diseases.

Authors:  Alok K Verma; Murli Manohar; Sathisha Upparahalli Venkateshaiah; Anil Mishra
Journal:  Cytokine Growth Factor Rev       Date:  2017-09-23       Impact factor: 7.638

Review 5.  Mini review: Neural mechanisms underlying airway hyperresponsiveness.

Authors:  Alexandra B Pincus; Allison D Fryer; David B Jacoby
Journal:  Neurosci Lett       Date:  2021-03-02       Impact factor: 3.046

Review 6.  Neuroimmune Pathophysiology in Asthma.

Authors:  Gandhi F Pavón-Romero; Nancy Haydée Serrano-Pérez; Lizbeth García-Sánchez; Fernando Ramírez-Jiménez; Luis M Terán
Journal:  Front Cell Dev Biol       Date:  2021-05-13

7.  Eosinophils in fungus-associated allergic pulmonary disease.

Authors:  Sumit Ghosh; Scott A Hoselton; Glenn P Dorsam; Jane M Schuh
Journal:  Front Pharmacol       Date:  2013-02-01       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.